{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:55:52Z","timestamp":1791428152771,"version":"4.3.3"},"reference-count":57,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007287","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["14-1275"],"award-info":[{"award-number":["14-1275"]}],"id":[{"id":"10.13039\/501100007287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF-2016-80535-R"],"award-info":[{"award-number":["SAF-2016-80535-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2015-70028-R"],"award-info":[{"award-number":["SAF2015-70028-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2016-75195-R"],"award-info":[{"award-number":["SAF2016-75195-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2017-82905-R"],"award-info":[{"award-number":["SAF2017-82905-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201319-30"],"award-info":[{"award-number":["201319-30"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,2,21]]},"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>CD6 is a lymphocyte surface co-receptor physically associated with the T-cell receptor (TCR)\/CD3 complex at the center of the immunological synapse. There, CD6 assists in cell-to-cell contact stabilization and modulation of activation\/differentiation events through interaction with CD166\/ALCAM (activated leukocyte cell adhesion molecule), its main reported ligand. While accumulating evidence is attracting new interest on targeting CD6 for therapeutic purposes in autoimmune disorders, little is known on its potential in cancer. In an attempt to elucidate the in vivo relevance of blocking CD6-mediated interactions in health and disease, we explored the consequences of expressing high circulating levels of a soluble form CD6 (sCD6) as a decoy receptor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>High sCD6 serum levels were achieved by using transgenic C57BL\/6 mice expressing human sCD6 under the control of lymphoid-specific transcriptional elements (shCD6LckE\u03bcTg) or wild type either transduced with hepatotropic adeno-associated virus coding for mouse sCD6 or undergoing repeated infusions of recombinant human sCD6 protein. Characterization of sCD6-induced changes was performed by ex vivo flow cytometry and functional analyses of mouse lymphoid organ cells. The in vivo relevance of those changes was explored by challenging mice with subcutaneous or metastatic tumors induced by syngeneic cancer cells of different lineage origins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Through a combination of in vitro and in vivo studies, we show that circulating sCD6 expression induces defective regulatory T cell (Treg) generation and function, decreased CD166\/ALCAM-mediated tumor cell proliferation\/migration and impaired galectin-induced T-cell apoptosis, supporting the fact that sCD6 modulates antitumor lymphocyte effector function and tumorigenesis. Accordingly, sCD6 expression in vivo resulted in delayed subcutaneous tumor growth and\/or reduced metastasis on challenge of mice with syngeneic cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Evidence is provided for the disruption of CD6 receptor\u2013ligand interactions as a feasible immunomodulatory approach in cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2019-000172","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T08:55:12Z","timestamp":1585212912000},"page":"e000172","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Multifaceted effects of soluble human CD6 in experimental cancer models"],"prefix":"10.1136","volume":"8","author":[{"given":"In\u00eas T","family":"Sim\u00f5es","sequence":"first","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Aranda","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Casad\u00f3-Llombart","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Velasco-de Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Catal\u00e0","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Departamento de Biolog\u00eda Molecular, Universidad de Cantabria-IDIVAL, Santander, Cantabria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Consuegra-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Orta-Mascar\u00f3","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Merino","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria, CSIC-UC, Santander, Cantabria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Merino","sequence":"additional","affiliation":[{"name":"Departamento de Biolog\u00eda Molecular, Universidad de Cantabria-IDIVAL, Santander, Cantabria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Alberola-Ila","sequence":"additional","affiliation":[{"name":"Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gonz\u00e1lez-Aseguinolaza","sequence":"additional","affiliation":[{"name":"Gene Therapy and Regulation of Gene Expression Program, Universidad de Navarra, Pamplona, Navarra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Carreras","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-4368","authenticated-orcid":false,"given":"Francisco","family":"Lozano","sequence":"additional","affiliation":[{"name":"Immunoreceptors del Sistema Innat i Adaptatiu, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalunya, Spain"},{"name":"Departament de Biomedicina, Facultat de Medicina, Universitat de Barcelona, Barcelona, Barcelona, Spain"},{"name":"Servei d'Immunologia, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"2025100315140324000_8.1.e000172.1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0161"},{"key":"2025100315140324000_8.1.e000172.2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2017.12.004","article-title":"Clinical and experimental evidence for targeting CD6 in immune-based disorders","volume":"17","author":"Consuegra-Fern\u00e1ndez","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2025100315140324000_8.1.e000172.3","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160201114308"},{"key":"2025100315140324000_8.1.e000172.4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.6.2213"},{"key":"2025100315140324000_8.1.e000172.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.05.064"},{"key":"2025100315140324000_8.1.e000172.6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1704008114"},{"key":"2025100315140324000_8.1.e000172.7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151785"},{"key":"2025100315140324000_8.1.e000172.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615253114"},{"key":"2025100315140324000_8.1.e000172.9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00769","article-title":"Human CD6 down-modulation following T-cell activation compromises lymphocyte survival and proliferative responses","volume":"8","author":"Carrasco","year":"2017","journal-title":"Front Immunol"},{"key":"2025100315140324000_8.1.e000172.10","first-page":"1056","article-title":"High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"40","author":"Ramos-Casals","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2025100315140324000_8.1.e000172.11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcrc.2015.04.120","article-title":"Pattern of soluble CD5 and CD6 lymphocyte receptors in critically ill patients with septic syndromes","volume":"30","author":"Aibar","year":"2015","journal-title":"J Crit Care"},{"key":"2025100315140324000_8.1.e000172.12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2262"},{"key":"2025100315140324000_8.1.e000172.13","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200424856"},{"key":"2025100315140324000_8.1.e000172.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3881"},{"key":"2025100315140324000_8.1.e000172.15","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270625"},{"key":"2025100315140324000_8.1.e000172.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2015.05.019"},{"key":"2025100315140324000_8.1.e000172.17","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.23.7019"},{"key":"2025100315140324000_8.1.e000172.18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.3.809"},{"key":"2025100315140324000_8.1.e000172.19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.4.1399"},{"key":"2025100315140324000_8.1.e000172.20","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270138"},{"key":"2025100315140324000_8.1.e000172.21","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.3.333"},{"key":"2025100315140324000_8.1.e000172.22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.7.3601"},{"key":"2025100315140324000_8.1.e000172.23","first-page":"e01391","article-title":"Protective effects of human and mouse soluble scavenger-like CD6 lymphocyte receptor in a lethal model of polymicrobial sepsis","volume":"61","author":"Mart\u00ednez-Florensa","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025100315140324000_8.1.e000172.24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00594","article-title":"Relevance of CD6-Mediated interactions in the regulation of peripheral T-cell responses and tolerance","volume":"8","author":"Consuegra-Fern\u00e1ndez","year":"2017","journal-title":"Front Immunol"},{"key":"2025100315140324000_8.1.e000172.25","doi-asserted-by":"crossref","first-page":"108156","DOI":"10.18632\/oncotarget.22564","article-title":"Immunomodulatory effects of soluble CD5 on experimental tumor models","volume":"8","author":"Sim\u00f5es","year":"2017","journal-title":"Oncotarget"},{"key":"2025100315140324000_8.1.e000172.26","article-title":"Injection of syngeneic murine melanoma cells to determine their metastatic potential in the lungs","volume":"111","author":"Timmons","year":"2016","journal-title":"J Vis Exp"},{"key":"2025100315140324000_8.1.e000172.27","first-page":"1207","article-title":"ILT3.Fc\u2013CD166 interaction induces inactivation of p70 S6 kinase and inhibits tumor cell growth","volume":"200","author":"Xu","year":"2018","journal-title":"J.i."},{"key":"2025100315140324000_8.1.e000172.28","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.94","article-title":"Bnip3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton","volume":"5","author":"Maes","year":"2014","journal-title":"Cell Death Dis"},{"key":"2025100315140324000_8.1.e000172.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-199950"},{"key":"2025100315140324000_8.1.e000172.30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020430","article-title":"Role of galectins in tumors and in clinical immunotherapy","volume":"19","author":"Chou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2025100315140324000_8.1.e000172.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1722434115"},{"key":"2025100315140324000_8.1.e000172.32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14737159.2016.1211932","article-title":"A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker","volume":"16","author":"Xiao","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"2025100315140324000_8.1.e000172.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0892-3"},{"key":"2025100315140324000_8.1.e000172.34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10585-019-09957-2","article-title":"Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM\/CD166","volume":"36","author":"von Lersner","year":"2019","journal-title":"Clin Exp Metastasis"},{"key":"2025100315140324000_8.1.e000172.35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.749804"},{"key":"2025100315140324000_8.1.e000172.36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cmi.2017.119","article-title":"Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis","volume":"15","author":"Consuegra-Fern\u00e1ndez","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"2025100315140324000_8.1.e000172.37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2018.02.004","article-title":"Targeting CD6 for the treatment of experimental autoimmune uveitis","volume":"90","author":"Zhang","year":"2018","journal-title":"J Autoimmun"},{"key":"2025100315140324000_8.1.e000172.38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1614336114"},{"key":"2025100315140324000_8.1.e000172.39","doi-asserted-by":"publisher","DOI":"10.1038\/ni1551"},{"key":"2025100315140324000_8.1.e000172.40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1296"},{"key":"2025100315140324000_8.1.e000172.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107247","article-title":"CD166\/ALCAM expression is characteristic of tumorigenicity and invasive and migratory activities of pancreatic cancer cells","volume":"9","author":"Fujiwara","year":"2014","journal-title":"PLoS One"},{"key":"2025100315140324000_8.1.e000172.42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3892\/or.2014.3226","article-title":"Cd166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through Akt","volume":"32","author":"Yu","year":"2014","journal-title":"Oncol Rep"},{"key":"2025100315140324000_8.1.e000172.43","first-page":"4362","article-title":"Regulatory T cells require TCR signaling for their suppressive function","volume":"194","author":"Schmidt","year":"2015","journal-title":"J.i."},{"key":"2025100315140324000_8.1.e000172.44","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2843"},{"key":"2025100315140324000_8.1.e000172.45","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00024-8"},{"key":"2025100315140324000_8.1.e000172.46","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1007\/s13277-015-3233-5","article-title":"Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer","volume":"36","author":"Tang","year":"2015","journal-title":"Tumor Biol."},{"key":"2025100315140324000_8.1.e000172.47","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1434467","article-title":"The role of galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment","volume":"7","author":"Farhad","year":"2018","journal-title":"Oncoimmunology"},{"key":"2025100315140324000_8.1.e000172.48","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.ajpath.2017.07.008","article-title":"Stromal expression of activated leukocyte cell adhesion molecule promotes lung tumor growth and metastasis","volume":"187","author":"Willrodt","year":"2017","journal-title":"Am J Pathol"},{"key":"2025100315140324000_8.1.e000172.49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039330","article-title":"Alcam regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells","volume":"7","author":"Jannie","year":"2012","journal-title":"PLoS One"},{"key":"2025100315140324000_8.1.e000172.50","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3892\/mmr.2014.2933","article-title":"Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation","volume":"11","author":"Ye","year":"2015","journal-title":"Mol Med Rep"},{"key":"2025100315140324000_8.1.e000172.51","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26377"},{"key":"2025100315140324000_8.1.e000172.52","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbamcr.2019.03.010","article-title":"Dual knockdown of galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM\/CD166), synergistically delays in vivo breast cancer growth","volume":"1866","author":"Ferragut","year":"2019","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"2025100315140324000_8.1.e000172.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.01.001"},{"key":"2025100315140324000_8.1.e000172.54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00350","article-title":"Cell-Mediated immunity to AAV vectors, evolving concepts and potential solutions","volume":"5","author":"Basner-Tschakarjan","year":"2014","journal-title":"Front Immunol"},{"key":"2025100315140324000_8.1.e000172.55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01217","article-title":"Commentary: CD6 as a potential target for treating multiple sclerosis","volume":"8","author":"Consuegra-Fern\u00e1ndez","year":"2017","journal-title":"Front Immunol"},{"key":"2025100315140324000_8.1.e000172.56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molmed.2018.02.008","article-title":"Untangling Galectin-driven regulatory circuits in autoimmune inflammation","volume":"24","author":"Toscano","year":"2018","journal-title":"Trends Mol Med"},{"key":"2025100315140324000_8.1.e000172.57","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm064"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2019-000172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:14:11Z","timestamp":1759529651000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2019-000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3,26]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/jitc-2019-000172"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2019-000172","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}